BridgeMD
New treatment option for Hepatitis C
Official title ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
ClinicalTrials.gov ID: NCT03685045
What this study is testing
- What it's testing
- The overall goals of the ETHOS II Project are to enhance hepatitis C virus (HCV) care in drug treatment clinics and needle and syringe programs (NSPs) in New South Wales and Australia, and to develop a translational framework for subsequent establishment of HCV screening and treatment programs in drug treatment clinics and NSPs across NSW and nationally.
- Time commitment: about 6 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Participant has voluntarily signed the informed consent form;
- 18 years of age or older;
- History of injecting drug use\ ;
- Recent injecting drug use (previous six months) or currently receiving OST\ .
- These criteria will not apply for recruitment from residential rehabilitation centres
The study team makes the final eligibility decision.
Where it's taking place
- Canberra, Australian Capital Territory, Australia
- Blacktown, New South Wales, Australia
- Brookvale, New South Wales, Australia
- Campbelltown, New South Wales, Australia
- Cessnock, New South Wales, Australia
- Coffs Harbour, New South Wales, Australia
- Darlinghurst, New South Wales, Australia
- Grafton, New South Wales, Australia
- Katoomba, New South Wales, Australia
- Kempsey, New South Wales, Australia
- Lismore, New South Wales, Australia
- Lithgow, New South Wales, Australia
- Liverpool, New South Wales, Australia
- Mount Druitt, New South Wales, Australia
- Newcastle, New South Wales, Australia
- Nowra, New South Wales, Australia
- Parramatta, New South Wales, Australia
- Port Macquarie, New South Wales, Australia
- Saint Leonards, New South Wales, Australia
- Tamworth, New South Wales, Australia
+ 12 more site(s).
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Canberra, Australian Capital Territory, Australia; Blacktown, New South Wales, Australia; Brookvale, New South Wales, Australia; Campbelltown, New South Wales, Australia; Cessnock, New South Wales, Australia; Coffs Harbour, New South Wales, Australia and 26 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.